Target intelligence / Profile preview

Synaptosomal-associated protein 29 (SNAP29)

Target
SNAP29
Molecular classification
SNARE protein, Vesicle fusion machinery, Membrane trafficking protein, Other
01

Overview

Synaptosomal-associated protein 29 (SNAP29) is a member of the SNARE family of proteins crucial for multiple cellular membrane trafficking pathways, including intracellular vesicle fusion, autophagy, and recycling processes[1][3][7]. Unlike the more plasma-membrane-localized SNAP25, SNAP29 binds tightly to multiple syntaxin proteins, is predominantly found on intracellular membrane structures, and also exists in the cytoplasm[1][3][5]. SNAP29 is directly involved in autophagosome-lysosome fusion, modulates synaptic transmission by regulating SNARE complex disassembly, mediates various trafficking steps (including endocytosis and recycling), and plays a role in cell division through kinetochore formation[3][5][7]. Loss-of-function mutations in SNAP29 cause CEDNIK syndrome (cerebral dysgenesis, neuropathy, ichthyosis, keratoderma), a rare neurocutaneous congenital disease characterized by severe neurological, skin, and developmental abnormalities[2][4][6][8]. Experimental evidence from both mouse and zebrafish models confirms SNAP29's requirement for proper neuromuscular and skin development, autophagy, and cell death regulation[4][6]. SNAP29 interacts with syntaxin family members, EHD1, and is associated with abnormal synaptic activity when its levels are altered, highlighting its role as a therapeutic target for diseases of membrane trafficking and neurodevelopment[5][6][7]. There are currently no drugs directly targeting SNAP29, and therapeutic interventions remain investigational[7][8].

Other names
SNAP-29Soluble 29 kDa NSF attachment proteinVesicle-membrane fusion protein SNAP-29CEDNIK proteinCerebral dysgenesis, neuropathy, ichthyosis and keratoderma syndrome proteinsynaptosome associated protein 29kDaSNAP29 (gene/protein symbol)
02

Biological functions

Intracellular membrane traffickingVesicle fusionAutophagosome-lysosome fusion (autophagy)Synaptic transmission modulationEndocytosisRecyclingCell division (kinetochore formation)Epidermal differentiationOther
03

Disease associations

Neurodevelopmental disorders (CEDNIK syndrome)Skin disorders (ichthyosis, keratoderma)NeuropathyCongenital syndromes (Cerebral dysgenesis)InfertilityOphthalmological abnormalitiesOther
04

Safety considerations

Loss-of-function associated with severe congenital syndromes (CEDNIK)Multisystem defects from deficiency (skin, neurodevelopment, fertility)No specific therapeutic agents; safety considerations relevant to gene therapy or SNARE-modulating interventions
05

Biomarkers

Reduced SNAP29 expression/mutation as a marker for CEDNIK syndromeSNAP29 genotyping for congenital ichthyosis/neurocutaneous syndromes

Beyond the preview

Go deeper on Synaptosomal-associated protein 29 (SNAP29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptosomal-associated protein 29 (SNAP29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call